Table II. Evidence for the role of NFAT in cellular adaptation.
Cell type | NFAT isoform implicated | Methods used to determine role for NFAT | Target gene | Function | References |
---|---|---|---|---|---|
Pancreatic islet cells (cell line) | NFATC2 | EMSA and reporter assays1 | Glucagon | Expression of glucagon | Furstenau et al., 1999 |
Epidermal cell (cell line) |
? | Reporter assays2 in vitro and in vivo | ? | Response to UV radiation | Huang et al., 2000 |
Cardiac muscle | NFATC4 | Overexpression in transgenic mice | ? | Cardiac hypertrophy | Molkentin et al., 1998 |
Skeletal myofibers (in vitro) | NFATC1 | Nuclear localization | ? | Response to nerve stimuli | Liu et al., 2001 |
Skeletal muscle cells (cell line) | ? | Reporter assays3 | MyHC II | Expression of MyHC II isoforms | Allen et al., 2001 |
VSMCs (primary cells) |
NFATC1/C2 | Reporter assays4 | ? | Agonist induced signaling | Boss et al., 1998 |
ISMCs (isolated tissue) |
NFATC3 | Nuclear localization; reporter assays5 | ? | Response to PDGF | Stevenson et al., 2001 |
EMSA, electrophoretic mobility shift assay.
Glucagon promoter constructs.
NFAT reporter construct; NFAT-luciferase transgenic mice.
MyHC II promoter constructs.
NFAT reporter construct.
NFAT-luciferase transgenic mice.